UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who struggle to take daily HIV pills may benefit from long-acting injectable ...

HIV incidence in sub-Saharan Africa has declined substantially, according to both UNAIDS estimates and empirical data pulled ...

Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about ...

Debates over tuberculosis reporting began in the late 19th century, when the bacterial infection was reframed not as a disease of the elite but of the urban poor. New York City was the first in the ...

Protein crystallization at the SER-CAT beamline at Argonne’s Advanced Photon Source proved key to the discovery of a new HIV vaccine candidate.

Researchers reveal new insights into the how the matrix layer of HIV-1 becomes matureResearchers from the Max Planck ...

To become infectious, HIV has to undergo a maturation process, which involves a rearrangement of the matrix proteins (red).

The classification of HIV/Aids and TB in the pandemics category, rather than chronic diseases, has made thousands of patients pay out-of-pocket for services that should be covered under the national ...

HIV self-testing is proving to be a revolutionary tool in Mizoram's fight against HIV/AIDS, offering a more private, convenient and effective means of diagnosis, the Health Ministry said on Tuesday.

A retrovirus is an infectious agent belonging to the RNA virus family Retroviridae ... of the matrix domain of the Gag protein of HIV-1 is induced by the proteolytic release and binding of ...